You're correct, I was mistaken. Although my mistake may actually help to support my stance.
It was used, and marketed, for morning sickness primarily in other countries (Germany in particular). It's an important distinction, because the US FDA actually stopped it's approval in the US. It seems that "only" about 20,000 American study participants were given the drug at that time. So more than half of the dead/deformed babies came from Germany.
Had the German equivalent of the FDA prevented the drug from going to market many babies might not have been born with deformities.
There are VERY good reasons to be slow in approving drugs that might impact a fetus.
It was used, and marketed, for morning sickness primarily in other countries (Germany in particular). It's an important distinction, because the US FDA actually stopped it's approval in the US. It seems that "only" about 20,000 American study participants were given the drug at that time. So more than half of the dead/deformed babies came from Germany.
Had the German equivalent of the FDA prevented the drug from going to market many babies might not have been born with deformities.
There are VERY good reasons to be slow in approving drugs that might impact a fetus.